Translate page


EHA Andreas Hochhaus




  • ELN 2020 treatment milestones
  • First-line therapy
  • ELN definitions of failure
  • ELN 2020 recommendations on treatment beyond 2nd line
  • Recommendations for switch: CP-CML
  • Biological features of progression 
  • Treatment-free remission
  • TKI and pregnancy
  • Strategic positioning of the new TKI: Asciminib
  • Overview of ELN Recommendations through the years                                                                                                             



Panel of experts:

  • Professor Andreas Hochhaus
    University of Jena (Germany)

Professor Andreas Hochhaus has personally answered the questions asked during the webinar. His answers can be found to the pdf